Jackson Grant Investment Advisers’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Jackson Grant Investment Advisers’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-324	Closed	-$15K	–	348
2022 Q3	$15K	Hold	324	–	–	0.01%	281
2022 Q2	$23K	Hold	324	–	–	0.01%	256
2022 Q1	$26K	Buy	+324	New	+$27.4K	0.01%	262
2021 Q4	–	Sell	-324	Closed	-$28K	–	356
2021 Q3	$28K	Hold	324	–	–	0.01%	265
2021 Q2	$29K	Hold	324	–	–	0.01%	264
2021 Q1	$25K	Hold	324	–	–	0.01%	267
2020 Q4	$22K	Buy	+324	New	+$20.2K	0.01%	252

Other funds holding SYNH

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

ClearBridge Investments New York $115B AUM 24.78% 1-Year Est. Return

Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $83.3B AUM 31.19% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Jackson Grant Investment Advisers's SYNH Position: Q4 2022 in Review

Jackson Grant Investment Advisers sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q4 2022, closing a stake of 324 shares — an estimated $15K sold.

Jackson Grant Investment Advisers first reported a position in SYNH in Q4 2020 and held it in 7 quarters. The position peaked at $29K in Q2 2021. 307 funds tracked by Wall St. Rank hold SYNH as of Q4 2022.

Jackson Grant Investment Advisers reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q4 2022 after selling out during the quarter.
Jackson Grant Investment Advisers sold 324 Syneos Health, Inc. Class A Common Stock shares in Q4 2022, an estimated $15K.
Jackson Grant Investment Advisers first reported a position in Syneos Health, Inc. Class A Common Stock in Q4 2020 and held it in 7 quarters.
Jackson Grant Investment Advisers's Syneos Health, Inc. Class A Common Stock position peaked at $29K in Q2 2021.
307 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q4 2022.

Based on Jackson Grant Investment Advisers's 13F filing for Q4 2022, filed 26 Jan 2023.